Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice

Journal of Neural Transmission

Volumn 103, Issue 7, 1996, Pages 819-831

  Gasior, M ^a   Kaminski R ^a   Brudniak, T ^a   Kleinrok, Z ^a   Czuczwar, S J ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Antiepileptics; Calcium channel inhibitors; Flunarizine; Nicardipine; Nimodipine; Pentylenetetrazol; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONAZEPAM; ETHOSUXIMIDE; FLUNARIZINE; NICARDIPINE; NIMODIPINE; PENTETRAZOLE; VALPROATE MAGNESIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; CALCIUM CHANNEL BLOCKERS; CLONAZEPAM; DRUG INTERACTIONS; ETHOSUXIMIDE; FLUNARIZINE; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NICARDIPINE; NIMODIPINE; PENTYLENETETRAZOLE; RANDOM ALLOCATION; SEIZURES; VALPROIC ACID;

EID: 0029801525     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01273360     Document Type: Article

References (42)

1. 1 receptors. Eur J Pharmacol 197: 221-223
2. Ashton D, Wauquier A (1986) Antagonism of hyperexcitability phenomena by calcium blockers in vitro and in vivo experiments. In: Speckmann E-J, Schulze H, Walden J (eds) Epilepsy and calcium. Urban and Schwarzenberg, Munich, pp 319-334
3. Bean BP (1989) Classes of calcium channels in vertebrate cells. Annu Rev Physiol 51: 367-384
4. Binnie CD, de Beukelaar F, Meijer JW, Meinardi H, Overweg J, Wauquier A, van Wieringen A (1985) Open dose-ranging trial of flunarizine as add-on therapy in epilepsy. Epilepsia 26: 424-428
5. Boissier JR, Tardy J, Diverres JC (1960) Une nouvelle methode simple pour explorer l'action "tranquilisante": le test de la cheminee. Med Exp (Basel) 3: 81-84
6. Chang T (1989) Ethosuximide. Absorption, distribution, and excretion. In: Levy R, Mattson R, Meldrum B, Pentry JK, Dreifuss FE (eds) Antiepileptic drugs. Raven Press, New York, pp 671-678
7. Czuczwar SJ, Chodkowska A, Kleinrok Z, Małek U, Jagiełło-Wójtowicz E (1990a) Effects of calcium channel inhibitors upon the efficacy of common antiepileptic drugs. Eur J Pharmacol 176: 75-83
8. Czuczwar SJ, Małek U, Kleinrok Z (1990b) Influence of calcium channel inhibitors upon the anticonvulsant efficacy of common antiepileptics against pentylenetetrazol-induced convulsions in mice. Neuropharmacology 29: 943-948
9. Czuczwar SJ, Ga̧sior M, Janusz W, Kleinrok Z (1992) Influence of flunarizine, nicardipine and nimodipine on the anticonvulsant activity of different antiepileptic drugs in mice. Neuropharmacology 31: 1179-1183
10. Czuczwar SJ, Gasior M, Kamiński R, Brudniak T, Turski WA, Kleinrok Z (1995) Influence of calcium channel inhibitors upon the anti-pentylenetetrazol activity of conventional antiepileptics in mice. Pharmacol Toxicol 76 [Suppl III]: R17
11. Czyrak A, Mogilnicka E, Maj J (1991) Some central pharmacological effects of the calcium channel antagonist flunarizine. J Neural Transm 83: 179-188
12. 3H)nitrobenzylthioinosine binding to the adenosine transporter in human brain. Eur J Pharmacol 238: 131-133
13. De Sarro GB, Meldrum BS, Nistico G (1988) Anticonvulsant effects of some calcium entry blockers in DBA/2 mice. Br J Pharmacol 93: 247-256
14. Desmedt LKC, Niemegeers CJE, Janssen PAJ (1976) Anticonvulsant properties of cinnarizine and flunarizine in mice. Arzneimittelforschung/Drug Res 25:1408-1413
15. 3H]dopamine uptake by flunarizine. Eur J Pharmacol 203: 67-69
16. Dolin SJ, Hunter AB, Halsey MJ, Little HJ (1988) Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine. Eur J Pharmacol 152: 19-27
17. Faingold CL (1992) Overview of ion channels, antiepileptic drugs, and seizures. In: Faingold CL, Fromm GH (eds) Drugs for control of epilepsy: action on neuronal networks involved in seizure disorders. CRC Press, Boca Raton, pp 57-68
18. Gasior M, Kleinrok Z, Czuczwar SJ (1995) Influence of BAY k-8644, a calcium channel agonist, on the anticonvulsant activity of conventional antiepileptics against electroconvulsions in mice. Neuropharmacology 34: 433-438
19. Heinemann U, Lux HD, Gutnic MJ (1977) Extracellular free calcium and potassium during paroxysmal activity in the cerebral cortex of the cat. Exp Brain Res 27: 237-243
20. Jagiełło-Wójtowicz E, Czuczwar SJ, Chodkowska E, Szponar J, Kleinrok Z (1991) Influence of calcium channel blockers on pentylenetetrazol and electroshock-induced convulsions in mice. Pol J Pharmacol Pharm 43: 95-101
21. Janis RA, Triggle DJ (1991) Drugs acting on calcium channels. In: Hurwitz LH, Partrige LD, Leach JK (eds) Calcium channels: their properties, function, regulation and clinical relevance. CRC Press, Boca Raton, pp 195-249
22. Larkin JG, McKee PJW, Blacklaw J, Thompson GG, Morgan IC, Brodie MJ (1991) Nimodipine in refractory epilepsy: a placebo-controlled, add-on study. Epilepsy Res 9: 71-77
23. Larkin JG, Thompson GG, Scobie G, Forrest G, Drennan JE, Brodie MJ (1992) Dihydropyridine calcium antagonists in mice: blood and brain pharmacokinetics and efficacy against pentylenetetrazol seizures. Epilepsia 33: 760-769
24. Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99-113
25. Löscher W, Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2:145-181
26. Middlemiss DN, Spedding M (1985) A functional correlate for the dihydropyridine binding site in rat brain. Nature 314: 94-96
27. Nakane Y, Seino M, Yagi A, Kaji S, Yamauchi T (1989) Effects of flunarizine therapy on intractable epilepsy. Arzneimittelforschung/Drug Res 39: 793-798
28. Onozuka M, Imai S, Ozono S (1987) Involvement of pentylenetetrazole in synapsin 1 phosphorylation associated with calcium influx in synaptosomes from rat cerebral cortex. Biochem Pharmacol 36: 1407-1415
29. Overweg J, Binnie CD, Meijer JWA, Meinardi H, Nuijten STM, Schmalz S, Wauquier A (1984) Double-blind placebo-controlled trial of flunarizine as add-on therapy in epilepsy. Epilepsia 25: 217-222
30. Palmer GC, Stagnitto ML, Ray RK, Knowles MA, Harvey R, Garske GE (1993) Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines. Epilepsia 34: 372-380
31. Phillis JW, Wu PH, Coffin VL (1983) Inhibition of adenosine uptake into rat brain synaptosomes by prostaglandins, benzodiazepines and other centrally active compounds. Gen Pharmacol 14: 475-479
32. Pohl M, Mareš P (1994) Influence of flunarizine on hippocampal epileptic afterdischarges in the rat. Physiol Res 43: 57-60
33. Rogawski MA, Porter RJ (1990) Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol Rev 42: 223-286
34. Sander JWAS (1993) Some aspects of prognosis in the epilepsies: a review. Epilepsia 34: 1007-1016
35. Schmidt D, Ried S (1989) Klinische Relevanz von Calcium-Antagonisten in der Behandlung von Epilepsien. Arzneimittelforschung/Drug Res 39: 156-158
36. Schwartzkroin PA, Wyler AR (1980) Mechanisms underlying epileptiform burst discharge. Ann Neurol 7: 95-107
37. Shelton RC, Grebb JA, Freed WJ (1987) Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k-8644. Brain Res 402: 399-402
38. Snead OC III (1995) Basic mechanisms of generalized absence seizures. Ann Neurol 37: 146-157
39. Speckmann EJ, Stroub H, Köhling R (1993) Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagonism. Neuropsychobiology 27: 122-126
40. Spending M, Paoletti R (1992) International Union of Pharmacology committee on receptor nomenclature and drug classification. III. Classification of calcium channels and the sites of action of drugs modifying channel function. Pharmacol Rev 44: 363-376
41. Uemastu D, Araki N, Greenberg H, Reivich M (1990) Alterations in cytosolic free calcium in the cat cortex during bicuculline-induced epilepsy. Brain Res Bull 24: 285-292
42. Yarbrough GG, McGuffin-Clineschmidt JC (1981) In vivo behavioral assessment of central nervous system purigenic receptors. Eur J Pharmacol 76: 137-144